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Abstract
KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine) is a novel potent and selective adenosine A1 receptor antagonist.
We examined the effect of KW-3902 on p-aminohippurate (PAH) transport in opossum kidney (OK) epithelial cells.
Pretreatment for 3 h with KW-3902 inhibited the transcellular transport of PAH across OK cell monolayers from the basal to
the apical side. The uptake of PAH across the basolateral membrane of OK cells was inhibited by KW-3902 pretreatment in
a time- and concentration-dependent manner. A kinetic analysis revealed that the inhibitory effect of KW-3902 on the
basolateral PAH uptake was due to an increase in the Michaelis constant (Km) as well as a decrease in the maximum uptake
rate (Vmax), showing that the inhibition was a mixed type. Pretreatment with adenosine deaminase or 8-cyclopentyl-1,3-
dipropylxanthine, another selective adenosine A1 receptor antagonist, also decreased the basolateral PAH uptake. KW-3902
pretreatment had no effect on the concentration of intracellular K-ketoglutarate which exchanges for PAH across the
basolateral membrane of OK cells. These results suggest that KW-3902 has an inhibitory effect on PAH transport in OK
epithelial cells. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The organic anion transport system in the renal
proximal tubule is the major system responsible for
the elimination of a wide variety of anionic com-
pounds, including endogenous metabolites, drugs
and xenobiotics or their metabolites [1,2]. This func-
tion is important physiologically because many or-
ganic anions are toxic and need to be removed as
promptly as possible. Several studies have indicated
that renal organic anion secretion could be modu-
lated by various exogenous and endogenous agents.
Gemba et al. [3] reported that tri£uoperazine, a
calmodulin antagonist, stimulated p-aminohippurate
(PAH), a typical organic anion, accumulation in rat
kidney cortical slices. Metabolic substrates such as
acetate, pyruvate, lactate and intermediates of the
citric acid cycle have been shown to stimulate organ-
ic anion transport in vitro and in vivo [4^7]. Further-
more, Halpin and Renfro [8] showed dopaminergic
inhibition and K-adrenergic stimulation of organic
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anion secretion by £ounder proximal tubule primary
cultures.
Cultured epithelial cells derived from the kidney
are useful for study on a variety of renal cellular
functions, including transcellular transport of solutes
such as organic cations [9^12] and regulation of
transport by hormones and drugs [13]. A series of
reports have demonstrated that OK cells, which
were established from the American opossum kidney
[14], are useful as an in vitro model system to study
the organic anion secretion in the renal proximal
tubules [15^17]. Recently, we showed that the PAH
transport in OK cells is under the regulatory control
of protein kinase C [18]. A subsequent work indi-
cated that parathyroid hormone (PTH) inhibits
PAH transport in OK cells, and that protein kinase
C activation is involved in the inhibitory e¡ect of
PTH on PAH transport [19].
Adenosine is an autacoid that regulates a number
of renal functions, including renal hemodynamics,
renin secretion and erythropoietin production, via
interactions with A1 and A2 adenosine receptors, dif-
ferentiated by a⁄nity for various adenosine ana-
logues. The A1 receptor is coupled to inhibition of
adenylate cyclase and/or activation of phospholipase
C, whereas the A2 receptor is coupled to adenylate
cyclase activation. It has been reported that adeno-
sine stimulates several transporters in the proximal
tubules, including Na^phosphate cotransporter [20],
Na^glucose cotransporter [20] and Na^3HCO33
cotransporter [21]. It was suggested that the increase
in Na^phosphate cotransport and Na^glucose co-
transport might contribute to the antidiuretic action
of adenosine and that the stimulation of the baso-
lateral Na^3HCO33 cotransport might reduce the
metabolic work of (Na+K)-ATPase, leading to
the conservation of ATP.
KW-3902 (8-(noradamantan-3-yl)-1,3-dipropyl-
xanthine) is a newly synthesized selective adenosine
A1 receptor antagonist [22]. KW-3902 has been
shown to induce signi¢cant diuretic and natriuretic
actions, resulting from an inhibition of water and
sodium reabsorption in tubular sites [23]. In addi-
tion, KW-3902 possesses a renal protective e¡ect in
rats with acute renal failure induced by cisplatin [24]
and cephaloridine [25]. It is reported that the neph-
rotoxicity of these drugs can also be reduced by co-
administration of probenecid, a typical organic anion
transport inhibitor, and other organic anions [26,27].
Therefore, the renal protective e¡ect of KW-3902
against cisplatin- and cephaloridine-induced acute re-
nal failure may be due to a decrease in the intra-
cellular concentration of these drugs in the renal
proximal tubular cells, following a change in renal
organic anion transport activity.
The purpose of this study is to examine whether
KW-3902 modulates the renal organic anion trans-
port, using OK epithelial cells. The results show that
KW-3902 inhibits PAH transport in OK cell mono-
layers.
2. Materials and methods
2.1. Cell culture
OK cells were cultured in medium 199 (Flow
Laboratories, Rockville, MD, USA) containing
10% fetal bovine serum (Whittaker Bioproducts,
Walkersville, MD, USA) without antibiotics, in an
atmosphere of 5% CO2^95% air at 37‡C, and sub-
cultured every 7 days using 0.02% EDTA and 0.05%
trypsin [15]. OK cells were used between passages
77 and 106.
2.2. Transport measurements
PAH transport was measured in OK cell mono-
layers cultured in Transwell chambers (Costar, Cam-
bridge, MA, USA). To prepare cell monolayers, cells
were seeded at a density of 4U105 cells/cm2 on poly-
carbonate membranes (3 Wm pore size) in Transwell
cell chambers (4.71 cm2 surface area), which were
placed in 6-well cluster plates. The volume of me-
dium inside and outside the chambers was 1.5 and
2.6 ml, respectively. Fresh medium was replaced
every 2 or 3 days, and the cells were used on the
5th or 6th day after seeding. Transport was measured
at 37‡C in Dulbecco’s phosphate-bu¡ered saline
(PBS bu¡er containing in mM, 137 NaCl, 3 KCl,
8 Na2HPO4, 1.5 KH2PO4, 1 CaCl2, and 0.5 MgCl2)
supplemented with 5 mM D-glucose.
The transcellular transport of [14C]PAH across
OK cell monolayers and cellular [14C]PAH uptake
were measured as described previously [15,17].
D-[3H]Mannitol was used to correct for paracellular
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£ux or extracellular trapping and non-speci¢c uptake
of PAH in each transport experiment.
2.3. Cell treatment
KW-3902, 8-cyclopentyl-1,3-dipropylxanthine
(DPCPX), phorbol 12-myristate 13-acetate (PMA)
and staurosporine were prepared in dimethyl sulfox-
ide (DMSO). The ¢nal concentration of DMSO dur-
ing exposure was 0.25^0.5%. The compounds were
applied to both the basolateral and apical sides for
a speci¢ed period unless stated. The control cells
were incubated with the same concentration of
DMSO in each experiment. Adenosine deaminase
(10 U/ml) was added to both the basolateral and
apical sides and incubated for 2 h. Finally, the cell
monolayers were washed three times with the PBS
containing 5 mM D-glucose before measuring the
PAH transport.
2.4. Analytical methods
The radioactivity was determined in 5 ml of ACSII
(Amersham International, Buckinghamshire, UK) by
liquid scintillation counting using an external stand-
ard to correct for quenching. The appropriate cross-
over correction was given to separate the radioactiv-
ities of 3H and 14C. Protein was determined by the
method of Bradford [28] with bovine Q-globulin as
the standard. Intracellular K-ketoglutarate concen-
tration was determined as described before [29].
Statistical analysis was performed by Student’s
t-test, or by the one-way analysis of variance with
the Sche¡e¤ test for post hoc analysis (P6 0.05 for
signi¢cance).
2.5. Materials
p-[glycyl-1-14C]Aminohippurate (1.53^2.0 GBq/
mmol) and D-[3H]mannitol (729 GBq/mmol) were
obtained from Du Pont-New England Nuclear (Bos-
ton, MA, USA). KW-3902 was a gift from Kyowa
Hakko Kogyo (Tokyo, Japan). PMA, DPCPX and
adenosine deaminase were purchased from Sigma
(St. Louis, MO, USA). Staurosporine was purchased
from Wako Pure Chemicals (Osaka, Japan). All oth-
er chemicals used were of the highest purity avail-
able.
3. Results
3.1. E¡ect of KW-3902 on the basal-to-apical PAH
transport
Fig. 1 shows the transcellular transport of
[14C]PAH across OK cell monolayers incubated in
the absence (control) or presence of KW-3902 for
3 h before transport measurements. Pretreatment
with 3 WM KW-3902 decreased the transcellular
transport of PAH from the basal side to the apical
side (71.8 þ 5.5% of control at 60 min £ux) (Fig. 1A),
and 30 WM KW-3902 more strongly inhibited the
transcellular PAH transport (30.6 þ 0.5% of control
at 60 min £ux) (Fig. 1B). To analyze further the
e¡ect of KW-3902 on PAH transport in OK cells,
we examined the e¡ects of KW-3902 on PAH uptake
across the basolateral membrane of OK cells.
3.2. E¡ect of KW-3902 pretreatment on basolateral
PAH transport
We examined the e¡ect of various concentrations
Fig. 1. E¡ect of 8-(noradamantan-3-yl)-1,3-dipropylxanthine
(KW-3902) on basal-to-apical transport of PAH by OK cell
monolayers. Con£uent monolayers were incubated for 3 h with-
out (open circles) or with (closed circles) KW-3902 of 3 WM
(A) and 30 WM (B). After washing the cells, [14C]PAH (15 WM)
and D-[3H]mannitol (15 WM) were added to the basal side of
monolayers. After 15, 30, 45, and 60 min, the medium on the
apical side was collected (100 Wl), and radioactivity levels
were counted to determine transcellular transport of [14C]PAH.
D-[3H]Mannitol was used to correct for paracellular £ux. Each
point represents the mean þ S.E. of three monolayers of a typi-
cal experiment.
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of KW-3902 on PAH uptake from the basal side of
OK cells. OK cells were treated with various concen-
trations (1^30 WM) of KW-3902 for 3 h, then the
basolateral PAH uptake for 1 min was measured.
As shown in Fig. 2, KW-3902 inhibited the basolat-
eral PAH uptake in a concentration-dependent man-
ner with an apparent half-maximal inhibitory con-
centration (IC50) of 10.7 WM.
Fig. 3 shows the e¡ect of KW-3902 (30 WM) pre-
treatment period (2 min^3 h) on PAH uptake from
the basal side of OK cells. Exposure to KW-3902
caused a time-dependent decrease in PAH uptake,
and it was signi¢cant in all the periods examined.
Then, the e¡ect of KW-3902 pretreatment side on
the basolateral PAH uptake was examined. Pretreat-
ment of 30 WM KW-3902 on either the apical or
basolateral side decreased the basolateral PAH up-
take, and showed a weaker inhibitory e¡ect than the
pretreatment of both sides (Fig. 4).
3.3. In£uence of KW-3902 on kinetic parameters of
basolateral PAH uptake
To determine the e¡ect of KW-3902 on the kinetic
parameters of PAH uptake from the basal side, OK
cells were incubated for 1 h in the absence or pres-
ence of KW-3902 (10 WM). The kinetic constants of
the basolateral PAH uptake in OK cells were ana-
lyzed by measuring the 1 min uptake of PAH over a
concentration range of 15^400 WM. As shown in Fig.
5, the basolateral PAH uptake was saturable and
inhibited by KW-3902 at all concentrations of PAH
examined. Eadie-Hofstee plots were linear in control
and KW-3902-treated cells (Fig. 5, inset). The Mi-
chaelis constants (Km) in the cells incubated without
and with KW-3902 were 53.0 þ 0.3 and 75.6 þ 4.0
WM, respectively (means þ S.E. of three experiments),
and the maximum uptake rates (Vmax) in the cells
incubated without and with KW-3902 were
222.0 þ 27.0 and 166.0 þ 25.1 pmol (mg protein)31
min31, respectively. Thus, the inhibition of the baso-
lateral PAH transport by KW-3902 was apparently a
mixed type.
Fig. 3. E¡ect of pretreatment time on KW-3902-induced inhibi-
tion of PAH uptake from the basal side of OK cell monolayers.
Con£uent monolayers were incubated for various periods (2, 5,
10, 15, 30, 60, and 180 min) with KW-3902 (30 WM) or its ve-
hicle (control), and [14C]PAH uptake from the basal side of
monolayers was measured as described in Fig. 2. The inset
shows PAH uptake in OK cells pretreated within 15 min. Each
point represents the mean þ S.E. of four monolayers of two sep-
arate experiments.
Fig. 2. Concentration-dependent e¡ect of KW-3902 on PAH
uptake from the basal side of OK cell monolayers. Con£uent
monolayers were incubated for 3 h with various concentrations
of KW-3902 (1^30 WM) or its vehicle. After washing the cells,
[14C]PAH (15 WM) and D-[3H]mannitol (15 WM) were added to
the basal side of monolayers, and [14C]PAH uptake for 1 min
at 37‡C was measured. Each point represents the mean þ S.E.
of four monolayers of two separate experiments. *P6 0.05, sig-
ni¢cant di¡erence from vehicle.
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3.4. E¡ect of staurosporine on KW-3902-induced
inhibition of basolateral PAH uptake in OK cells
Previous results showed that PAH transport in
OK cells was inhibited by activation of protein ki-
nase C [18]. Therefore, we examined whether the KW-
3902-induced inhibitory e¡ect of PAH transport in
OK cells is due to activation of protein kinase C. As
a result, staurosporine, a protein kinase C inhibitor,
had no e¡ect on the inhibition of PAH transport by
KW-3902, though it blocked the inhibition by PMA,
a protein kinase C activator (Fig. 6).
3.5. E¡ect of KW-3902 on intracellular
K-ketoglutarate concentration
Recent reports suggest that K-ketoglutarate is a
major physiological dicarboxylate participating in or-
ganic anion secretion via PAH/dicarboxylate ex-
change [1,6,30], and PAH/dicarboxylate exchange is
modulated by changes in the intracellular concentra-
tion of K-ketoglutarate [6,29]. Therefore, we exam-
ined whether KW-3902 a¡ects intracellular K-keto-
Fig. 6. E¡ect of staurosporine on KW-3902-induced inhibition
of PAH uptake from the basal side of OK cell monolayers.
Con£uent monolayers were exposed for 15 min to 1 WM stauro-
sporine or its vehicle, followed by an additional 3 h incubation
in the absence (control; open columns) or the presence of 10
WM KW-3902 (solid columns) or 100 nM PMA (hatched col-
umns). After washing the cells, [14C]PAH (15 WM) uptake from
the basal side of monolayers was measured as described in Fig.
2. Each column represents the mean þ S.E. of four monolayers
of two separate experiments. *P6 0.05, signi¢cant di¡erence
from each control.
Fig. 5. In£uence of KW-3902 on kinetic parameters of PAH
uptake from the basal side of OK cell monolayers. Con£uent
monolayers were incubated for 1 h in the absence (open circles)
or presence (closed circles) of KW-3902 (10 WM), and [14C]PAH
uptake from the basal side of monolayers was measured as de-
scribed in Fig. 2. Inset: Eadie-Hofstee plots of the data. Each
point represents the mean þ S.E. of three separate experiments.
Fig. 4. E¡ect of KW-3902 pretreatment side on PAH uptake
from the basal side of OK cell monolayers. KW-3902 (¢nal 30
WM) was applied to the basolateral and/or apical side of mono-
layers for 15 min. After washing the cells, [14C]PAH uptake for
1 min from the basal side of monolayers was measured as de-
scribed in Fig. 2. Each column represents the mean þ S.E. of
three monolayers of a typical experiment.
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glutarate concentration. However, the intracellular
K-ketoglutarate concentration was not signi¢cantly
changed by KW-3902 pretreatment (0.3^30 WM con-
centration) (Fig. 7).
3.6. E¡ect of adenosine deaminase and DPCPX on
basolateral PAH uptake
To determine whether endogenous adenosine is in-
volved in PAH transport in OK cells, OK cells were
pretreated for 2 h with adenosine deaminase (10 U/
ml) to remove endogenous adenosine. As shown in
Fig. 8, adenosine deaminase pretreatment signi¢-
cantly decreased the basolateral PAH uptake. More-
over, we studied the e¡ect of DPCPX, another selec-
tive adenosine A1 receptor antagonist, on the
basolateral PAH uptake in OK cells. The basolateral
PAH uptake was signi¢cantly inhibited by pretreat-
ment for 3 h with 30 WM DPCPX (Fig. 8). Thus, the
e¡ect of KW-3902 on PAH uptake was at least in
part mediated by the adenosine receptor blockage.
4. Discussion
It has been reported that KW-3902 showed signi¢-
cant diuretic and natriuretic actions, being due to
inhibition of water and sodium reabsorption mainly
in the proximal tubule [22,23]. Furthermore, Cai et
al. [31,32] observed that KW-3902 inhibited sodium-
dependent phosphate transport in rat cultured prox-
imal tubular cells. In addition, Nagashima et al. [25]
reported that KW-3902 possesses a renal protective
e¡ect in rats with cephaloridine-induced acute renal
failure, which might be due to the inhibition of renal
organic anion transport by KW-3902. Thus, KW-
3902 might modulate the activity of the organic
anion transporter in renal proximal tubular cells.
Therefore, we examined the e¡ect of KW-3902 on
PAH transport in OK cells, which are a useful in
vitro model system to study the organic anion trans-
port across intact epithelial cells.
In the present study, KW-3902 inhibited the trans-
cellular transport of PAH from the basal to the ap-
ical side in OK cells. Furthermore, the basolateral
PAH uptake in OK cells was inhibited by KW-
3902 in a pretreatment time- and concentration-de-
pendent manner. The kinetic analysis in the present
study revealed an increase in Km and a decrease in
Vmax by KW-3902 pretreatment, showing that the
Fig. 8. E¡ect of adenosine deaminase (ADA) and DPCPX on
PAH uptake from the basal side of OK cell monolayers. Con-
£uent monolayers were incubated for 2 h with ADA (10 U/ml)
or for 3 h with DPCPX (30 WM). The control cells were incu-
bated with its vehicle. After washing the cells, [14C]PAH
(15 WM) uptake from the basal side of monolayers was meas-
ured as described in Fig. 2. Each column represents the
mean þ S.E. of three monolayers of a typical experiment.
*P6 0.05, signi¢cant di¡erence from each control.
Fig. 7. E¡ect of KW-3902 on the intracellular K-ketoglutarate
concentration in OK cell monolayers. Con£uent monolayers
were exposed to various concentrations of KW-3902 (0.3^30
WM) or its vehicle for 3 h. After washing the cells, intracellular
K-ketoglutarate concentration was determined. Each point rep-
resents the mean þ S.E. of four monolayers.
BBAMEM 77614 6-7-99
J. Nagai et al. / Biochimica et Biophysica Acta 1419 (1999) 164^172 169
inhibition by KW-3902 was a mixed type. On the one
hand, our previous report showed that the inhibition
by benzylpenicillin, an organic anion, was a compet-
itive type because the analysis showed an increase in
Km without changing Vmax [16]. In addition, the ap-
plication of KW-3902 to the apical side of OK cells
showed an inhibitory e¡ect on the PAH uptake from
the basal side to which KW-3902 was not applied.
Thus, the inhibitory e¡ect of KW-3902 on PAH
transport in OK cells seems to be due to not the
competitive interaction with the PAH transport but
to the change in the PAH transport activity.
The concentration-response relationship for the
KW-3902-induced inhibition of basolateral PAH up-
take in OK cells (IC50 = 10.7 WM) was not so di¡er-
ent from that of phosphate transport in the rat cul-
tured renal proximal tubular cells (IC50 = 2.0 WM),
reported by Cai et al. [31]. However, there are several
di¡erences of KW-3902-induced inhibitory character-
istics between PAH transport and phosphate trans-
port. The pretreatment of KW-3902 for 15 min
showed the maximal inhibition of the basolateral
PAH transport, whereas it did not signi¢cantly in-
hibit the phosphate transport [31]. Furthermore, a
kinetic analysis showed that KW-3902 elicited a de-
crease in both the maximal velocity and the a⁄nity
of basolateral PAH uptake, while it has been re-
ported that the a⁄nity of phosphate transport was
not changed by KW-3902 [31]. Thus, it is likely that
KW-3902 a¡ects various transporters in the kidney,
and that the mechanisms of regulation vary with
transporters.
We observed that removal of endogenous adeno-
sine by adenosine deaminase signi¢cantly decreased
the basolateral PAH uptake in OK cells. Further-
more, DPCPX, another selective adenosine A1 recep-
tor antagonist, inhibited the basolateral PAH uptake
in OK cells. Therefore, it is likely that the e¡ect of
KW-3902 on PAH uptake was, at least in part, medi-
ated by the adenosine receptor blockage. On one
hand, the concentration (3 WM) at which KW-3902
a¡ected the basolateral PAH transport was much
higher than the dissociation constant value (1.3
nM) of KW-3902 for adenosine A1 receptor. There-
fore, the possibility that other mechanisms rather
than the adenosine receptor-mediated regulation are
involved in the action of KW-3902 could not be ex-
cluded. However, the inhibitory e¡ect of the baso-
lateral PAH transport by the apical pretreatment of
KW-3902 suggests the involvement of a receptor-
mediated regulation, though the speci¢c receptor re-
mains to be clari¢ed in the present work.
Adenosine A receptors are supposed to be coupled
to phospholipase C and/or adenylate cyclase through
the inhibitory guanosine 5P-triphosphate-binding
protein Gi [33]. Thus, the adenosine receptor appears
to be coupled to intracellular regulatory pathways,
including activation and/or inhibition of protein ki-
nase C and protein kinase A. Our previous results
showed that PAH transport in OK cells was inhib-
ited by the activation of protein kinase C [18], while
it was not a¡ected by protein kinase A activators
[19]. Therefore, we examined whether the KW-
3902-induced inhibition of PAH transport in OK
cells was due to the activation of protein kinase C.
As a result, staurosporine, a protein kinase C inhib-
itor, did not recover the decrease in the PAH trans-
port activity by KW-3902. Thus, protein kinase C
activation does not seem to be involved in the inhib-
itory e¡ect of KW-3902 on PAH transport in OK
cells.
Studies with basolateral membrane vesicles, renal
cortical slices, and isolated renal tubules have shown
that PAH is transported via PAH/dicarboxylate ex-
change in renal basolateral membrane, and that K-
ketoglutarate could be a physiological substrate for
PAH/dicarboxylate exchange [6,30,34,35]. In addi-
tion, PAH transport in rat renal cortical slices was
modulated by changes in intracellular K-ketogluta-
rate concentration or the outwardly oriented K-keto-
glutarate gradient [6]. In OK cells, we found that the
basolateral PAH uptake was inhibited in accordance
with the decrease in the intracellular K-ketoglutarate
concentration [29]. Therefore, we examined whether
the KW-3902-induced inhibitory e¡ect on PAH
transport in OK cells is due to changes of intracel-
lular K-ketoglutarate concentration. The intracellular
K-ketoglutarate concentration in OK cells, however,
was not signi¢cantly a¡ected by KW-3902. Thus, it is
likely that the inhibitory e¡ect of KW-3902 on the
PAH transport is mediated by a mechanism inde-
pendent of decrease in intracellular K-ketoglutarate
concentration. Further studies are needed to clarify
the mechanism underlying the inhibition of PAH
transport by KW-3902.
In the present study, we showed that KW-3902
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inhibits both the transcellular transport of PAH from
the basal to the apical side and the basolateral PAH
transport in OK cells. It is possible that the inhibi-
tion by KW-3902 of the basolateral organic anion
transport reduces the accumulation of anionic drugs
in the renal proximal tubular cells. Therefore, the
present result might explain the protective e¡ect of
KW-3902 against the nephrotoxicity induced by cis-
platin and cephaloridine, which was reported previ-
ously in in vivo experiments [24,25].
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